Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
2021
Abstract Background REGEN-COV (previously known as REGN-COV2), a combination of the monoclonal antibodies casirivimab and imdevimab, has been shown to markedly reduce the risk of hospitalization or...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
7
References
38
Citations
NaN
KQI